Joan Choo

415 total citations
21 papers, 217 citations indexed

About

Joan Choo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Joan Choo has authored 21 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Joan Choo's work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Joan Choo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Joan Choo collaborates with scholars based in Singapore, United States and United Kingdom. Joan Choo's co-authors include Shahir Hamdulay, Paul C. Evans, Odile Dumont, Anna M. Randi, Damien Calay, Allen M. Samarel, Justin C. Mason, Andrea S. Bauer, John B. G. Mackey and Joseph J. Boyle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Biochemical Journal.

In The Last Decade

Joan Choo

19 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joan Choo Singapore	8	88	76	47	35	29	21	217
Huimin Zou China	9	41 0.5×	71 0.9×	26 0.6×	49 1.4×	51 1.8×	24	240
Daniela Gabriela Bălan Romania	9	52 0.6×	71 0.9×	58 1.2×	16 0.5×	42 1.4×	32	240
Xiaoya Xu China	10	67 0.8×	84 1.1×	48 1.0×	45 1.3×	36 1.2×	25	289
Sandy Ferber United States	7	110 1.3×	133 1.8×	24 0.5×	40 1.1×	21 0.7×	9	277
Yiming Lv China	11	68 0.8×	121 1.6×	75 1.6×	41 1.2×	50 1.7×	26	295
Yaping Dong China	10	64 0.7×	100 1.3×	49 1.0×	32 0.9×	60 2.1×	20	259
Yizhen Liu China	11	64 0.7×	132 1.7×	54 1.1×	31 0.9×	54 1.9×	38	288
Varinder Kaur United States	8	63 0.7×	68 0.9×	21 0.4×	47 1.3×	13 0.4×	41	270
Ugo Chianese Italy	10	54 0.6×	149 2.0×	24 0.5×	19 0.5×	47 1.6×	27	251
Yujiao Sun China	9	34 0.4×	109 1.4×	22 0.5×	23 0.7×	42 1.4×	18	226

Countries citing papers authored by Joan Choo

Since Specialization

Citations

This map shows the geographic impact of Joan Choo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Choo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Choo more than expected).

Fields of papers citing papers by Joan Choo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Choo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Choo. The network helps show where Joan Choo may publish in the future.

Co-authorship network of co-authors of Joan Choo

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Choo. A scholar is included among the top collaborators of Joan Choo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Choo. Joan Choo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choo, Joan, et al.. (2025). The effect of oral methadone on the QTc interval in cancer pain patients. Pain Management. 15(1). 21–25. 2 indexed citations

Choo, Joan, et al.. (2025). A phase I trial of intraperitoneal (IP) mesothelin (MSLN)-targeted CAR T-cell therapy in patients with MSLN-positive esophagogastric cancer (EGC) with peritoneal carcinomatosis.. Journal of Clinical Oncology. 43(4_suppl).

Choo, Joan, Jieming Zeng, Sudipto Bari, et al.. (2024). Abstract CT160: A phase I trial to evaluate allogeneic NKG2DL-targeting chimeric antigen receptor-grafted γδ T cells in subjects with advanced solid tumors or hematological malignancies (the ANGELICA Trial). Cancer Research. 84(7_Supplement). CT160–CT160. 1 indexed citations

Choo, Joan, Bernadette Reyna Asuncion, Benjamin Kye Jyn Tan, et al.. (2023). Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer. Gastric Cancer. 26(3). 393–404. 12 indexed citations

Lim, Joline S.J., Samuel G.W. Ow, Andrea L.A. Wong, et al.. (2023). Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines. European Journal of Cancer. 193. 113311–113311. 1 indexed citations

Choo, Joan, Philip S. Low, Chee Siang Ang, et al.. (2023). 593P Role of circulating tumor DNA (ctDNA) in assessing primary anti–epidermal growth factor receptor (EGFR) resistance in untreated RAS/BRAF wild-type (WT) metastatic colorectal cancer (mCRC) patients (pts). Annals of Oncology. 34. S429–S429. 1 indexed citations

Choo, Joan, Sun Young Rha, Haining Tan, et al.. (2022). 1255P da VINci: Safety and efficacy of the OTSGC-A24 vaccine and nivolumab in metastatic gastric cancer. Annals of Oncology. 33. S1121–S1121.

Choo, Joan, Yi‐Hua Jan, Samuel G.W. Ow, et al.. (2022). Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors. Targeted Oncology. 17(3). 355–368. 1 indexed citations

Yeong, Joe, Chong Boon Teo, Benjamin Kye Jyn Tan, et al.. (2022). Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 4026–4026. 2 indexed citations

10.

Huang, Yiqing, Joseph J. Zhao, Yu Yang Soon, et al.. (2022). Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer. Thoracic Cancer. 13(22). 3152–3161. 20 indexed citations

11.

Walsh, Robert J., Joan Choo, Jingshan Ho, et al.. (2022). Real-world experience on the efficacy and tolerability of biweekly trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.. Journal of Clinical Oncology. 40(16_suppl). 3584–3584. 2 indexed citations

12.

Lim, Joline S.J., Joan Choo, Samuel G.W. Ow, et al.. (2021). Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer. Breast Cancer Research and Treatment. 192(1). 131–142. 13 indexed citations

13.

Chia, Daryl Kai Ann, Raghav Sundar, Guowei Kim, et al.. (2021). Outcomes of a phase II study of intraperitoneal paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases.. Journal of Clinical Oncology. 39(3_suppl). 165–165. 6 indexed citations

14.

Zhao, Joseph J., Nesaretnam Barr Kumarakulasinghe, Matilda Lee, et al.. (2021). Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience. Oncology. 99(3). 192–202. 16 indexed citations

15.

Huang, Yiqing, Joan Choo, Natalie Y.L. Ngoi, et al.. (2020). Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre. Lung Cancer. 146. 145–153. 21 indexed citations

16.

Lim, Joline S.J., Andrea Li Ann Wong, Samuel G.W. Ow, et al.. (2020). Clinical efficacy and molecular effects of lenvatinib (Len) and letrozole (Let) in hormone receptor-positive (HR+) metastatic breast cancer (MBC).. Journal of Clinical Oncology. 38(15_suppl). 1019–1019. 1 indexed citations

17.

Huang, Yiqing, Yvonne Ang, Wan Qin Chong, et al.. (2020). Cost and efficacy of low-dose pembrolizumab in the treatment of non-small cell lung cancer patients in Asia.. Journal of Clinical Oncology. 38(15_suppl). e19385–e19385. 2 indexed citations

18.

Sundar, Raghav, Samuel G.W. Ow, Gloria Chan, et al.. (2020). Concomitant limb cryocompression and scalp cooling to reduce paclitaxel-induced neuropathy and alopecia.. Journal of Clinical Oncology. 38(15_suppl). e24157–e24157. 1 indexed citations

19.

Dumont, Odile, Andrea S. Bauer, John B. G. Mackey, et al.. (2015). PKCε-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosis. Cardiovascular Research. 106(3). 509–519. 90 indexed citations

20.

Dumont, Odile, Andrea S. Bauer, Damien Calay, et al.. (2012). Protein kinase Cϵ activity induces anti-inflammatory and anti-apoptotic genes via an ERK1/2- and NF-κB-dependent pathway to enhance vascular protection. Biochemical Journal. 447(2). 193–204. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact